These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30705370)
1. Identification of recurrent fusion genes across multiple cancer types. Yu YP; Liu P; Nelson J; Hamilton RL; Bhargava R; Michalopoulos G; Chen Q; Zhang J; Ma D; Pennathur A; Luketich J; Nalesnik M; Tseng G; Luo JH Sci Rep; 2019 Jan; 9(1):1074. PubMed ID: 30705370 [TBL] [Abstract][Full Text] [Related]
2. Detection of fusion gene transcripts in the blood samples of prostate cancer patients. Yu YP; Liu S; Nelson J; Luo JH Sci Rep; 2021 Aug; 11(1):16995. PubMed ID: 34417538 [TBL] [Abstract][Full Text] [Related]
3. Novel fusion transcripts associate with progressive prostate cancer. Yu YP; Ding Y; Chen Z; Liu S; Michalopoulos A; Chen R; Gulzar ZG; Yang B; Cieply KM; Luvison A; Ren BG; Brooks JD; Jarrard D; Nelson JB; Michalopoulos GK; Tseng GC; Luo JH Am J Pathol; 2014 Oct; 184(10):2840-9. PubMed ID: 25238935 [TBL] [Abstract][Full Text] [Related]
4. Detection of fusion transcripts in the serum samples of patients with hepatocellular carcinoma. Yu YP; Tsung A; Liu S; Nalesnick M; Geller D; Michalopoulos G; Luo JH Oncotarget; 2019 May; 10(36):3352-3360. PubMed ID: 31164957 [TBL] [Abstract][Full Text] [Related]
5. The landscape and therapeutic relevance of cancer-associated transcript fusions. Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544 [TBL] [Abstract][Full Text] [Related]
6. MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. Chen ZH; Yu YP; Tao J; Liu S; Tseng G; Nalesnik M; Hamilton R; Bhargava R; Nelson JB; Pennathur A; Monga SP; Luketich JD; Michalopoulos GK; Luo JH Gastroenterology; 2017 Oct; 153(4):1120-1132.e15. PubMed ID: 28245430 [TBL] [Abstract][Full Text] [Related]
7. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer. Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829 [TBL] [Abstract][Full Text] [Related]
8. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662 [TBL] [Abstract][Full Text] [Related]
9. Commonality but diversity in cancer gene fusions. Rabbitts TH Cell; 2009 May; 137(3):391-5. PubMed ID: 19410533 [TBL] [Abstract][Full Text] [Related]
10. [TMPRSS2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens]. Xiao L; Zhu XZ; Wang Y; Gong Y; Guo CC Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):392-6. PubMed ID: 21914348 [TBL] [Abstract][Full Text] [Related]
11. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications. Shah RB; Chinnaiyan AM Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877 [TBL] [Abstract][Full Text] [Related]
12. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes. Earp MA; Raghavan R; Li Q; Dai J; Winham SJ; Cunningham JM; Natanzon Y; Kalli KR; Hou X; Weroha SJ; Haluska P; Lawrenson K; Gayther SA; Wang C; Goode EL; Fridley BL Oncotarget; 2017 Jul; 8(29):46891-46899. PubMed ID: 28423358 [TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing approach for detecting 491 fusion genes from human cancer. Urakami K; Shimoda Y; Ohshima K; Nagashima T; Serizawa M; Tanabe T; Saito J; Usui T; Watanabe Y; Naruoka A; Ohnami S; Ohnami S; Mochizuki T; Kusuhara M; Yamaguchi K Biomed Res; 2016; 37(1):51-62. PubMed ID: 26912140 [TBL] [Abstract][Full Text] [Related]
14. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis. Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973 [TBL] [Abstract][Full Text] [Related]
16. Fusion genes in solid tumors: the possibilities and the pitfalls. Barr FG Expert Rev Mol Diagn; 2016 Sep; 16(9):921-3. PubMed ID: 27550633 [No Abstract] [Full Text] [Related]
17. Genetic fusions favor tumorigenesis through degron loss in oncogenes. Liu J; Tokheim C; Lee JD; Gan W; North BJ; Liu XS; Pandolfi PP; Wei W Nat Commun; 2021 Nov; 12(1):6704. PubMed ID: 34795215 [TBL] [Abstract][Full Text] [Related]
18. Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies. Shaver TM; Lehmann BD; Beeler JS; Li CI; Li Z; Jin H; Stricker TP; Shyr Y; Pietenpol JA Cancer Res; 2016 Aug; 76(16):4850-60. PubMed ID: 27231203 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of novel fusion genes in prostate cancer by targeted RNA capture and next-generation sequencing. Yang J; Chen Y; Lu J; Wang X; Wang L; Liang J; Sun ZS Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1166-1172. PubMed ID: 30307468 [TBL] [Abstract][Full Text] [Related]
20. Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Hahn Y; Bera TK; Gehlhaus K; Kirsch IR; Pastan IH; Lee B Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13257-61. PubMed ID: 15326299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]